Latest News

Biokangtai: Recombinant COVID-19 Vaccine(Adenovirus Vector) licensed for manufacturing, which actively promotes vaccine export and improves vaccine accessibility

SHENZHEN, China, Sept. 8, 2021 /PRNewswire/ -- The other day Shenzhen Kangtai Biological Products C...

2021-09-09 11:40 2417

BIOKANGTAI COVID-19 Vaccine Approved for Phase III Clinical Trial in the Philippines

SHENZHEN, China, Aug. 2, 2021 /PRNewswire/ -- On July 30, Shenzhen Kangtai Biological Products Co.,...

2021-08-02 15:25 4429

Phase III Clinical Trial of BIOKANGTAI COVID-19 Vaccine Initiated in Malaysia

SHENZHEN, China, June 22, 2021 /PRNewswire/ -- On June 21, local time, phase III clinical fieldwork...

2021-06-22 22:32 8608